# Weekly TP-HDFL in the Treatment of Advanced TCC

> **NCT00154687** · PHASE2 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Transitional Cell Carcinoma

## Interventions

- **DRUG:** Paclitaxel, Cisplatin, 5-Fluorouracil

## Key facts

- **NCT ID:** NCT00154687
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2007-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154687, "Weekly TP-HDFL in the Treatment of Advanced TCC". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00154687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*